Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in neuroleptic-induced tardive dyskinesia
NCT00175955Phase 2Completed
- Sponsor
- UCB
- Start
- May 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in tardive dyskinesia (TD) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Reduction in neuroleptic-induced tardive dyskinesia at 8 weeks. Started May 2005; status: completed.
02
Drugs
levetiracetam
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT00175955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175955.